||||||||||albumin-interferon alpha2b fusion protein / FortuneRock (China) Trial completion, Trial primary completion date: Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Chinese Healthy Volunteers (clinicaltrials.gov) - May 8, 2017 P1, N=34, Completed, Sponsor: Tianjin SinoBiotech Ltd. Trial completion date: May 2019 --> Oct 2019 Recruiting --> Completed | Trial primary completion date: Feb 2017 --> Aug 2016